Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences
Abstract Background For patients receiving daily opioid agonist treatment (OAT) for opioid dependence, several countries relaxed treatment guidelines at the beginning of the COVID-19 pandemic. This involved longer take-home intervals for methadone and buprenorphine doses as well as a reduction in su...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2023-09-01
|
| Seri Bilgileri: | BMC Health Services Research |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12913-023-09959-7 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|